End Cash: The amount of cash held by the company for the given period.
Dogwood Therapeutics, Inc (DWTX) had End Cash of $17.54M for the most recently reported fiscal quarter, ending 2025-03-31.
Income Statement Financials | |
-- |
|
$-12.18M |
|
-- |
|
-- |
|
$4.43M |
|
$-4.43M |
|
$-6.30M |
|
$-10.73M |
|
$-10.73M |
|
$-10.93M |
|
$-10.93M |
|
$-10.93M |
|
$-10.93M |
|
$-4.43M |
|
$-4.36M |
|
1.44M |
|
1.44M |
|
$-8.45 |
|
$-8.45 |
|
Balance Sheet Financials | |
$19.16M |
|
$0.02M |
|
$77.82M |
|
$96.98M |
|
$2.58M |
|
-- |
|
$11.66M |
|
$14.24M |
|
$-17.91M |
|
$5.16M |
|
$82.75M |
|
1.91M |
|
Cash Flow Statement Financials | |
$-4.68M |
|
-- |
|
$7.37M |
|
$14.85M |
|
End Cash |
$17.54M |
$2.69M |
|
$0.08M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
7.43 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.68M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
61.01% |
|
-211.89% |
|
-11.26% |
|
-13.20% |
|
$43.30 |
|
$-3.25 |
|
$-3.25 |